Laminin promotes differentiation of NB4 promyelocytic leukemia cells with all-trans retinoic acid
暂无分享,去创建一个
[1] G. Lozano,et al. PML, a growth suppressor disrupted in acute promyelocytic leukemia , 1994, Molecular and cellular biology.
[2] M. Lanotte,et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] H. Koeffler,et al. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. , 1994, Blood.
[4] K. Kolibaba,et al. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. , 1994, Blood.
[5] R. Evans,et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein , 1994, Cell.
[6] Maria Carmo-Fonseca,et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.
[7] P. Pandolfi,et al. Acute promyelocytic leukemia: from genetics to treatment. , 1994, Blood.
[8] C. Damsky,et al. Developmental regulation of integrin expression at the time of implantation in the mouse embryo. , 1993, Development.
[9] P. Hartfield,et al. β1 Integrin-Mediated T Cell Adhesion Is Regulated by Calcium Ionophores and Endoplasmic Reticulum Ca2+-ATPase Inhibitors , 1993 .
[10] A. Sonnenberg,et al. Variants of the alpha 6 beta 1 laminin receptor in early murine development: distribution, molecular cloning and chromosomal localization of the mouse integrin alpha 6 subunit. , 1993, Cell adhesion and communication.
[11] H. V. Van Wart,et al. Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells. , 1992, The Journal of biological chemistry.
[12] R. Berger,et al. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. , 1992, Leukemia.
[13] O. Bjerrum,et al. Activation of the oxygen-radical-generating system in granules of intact human neutrophils by a calcium ionophore (ionomycin). , 1992, Biochimica et biophysica acta.
[14] P. Chambon,et al. Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.
[15] R Langer,et al. Switching from differentiation to growth in hepatocytes: Control by extracellular matrix , 1992, Journal of cellular physiology.
[16] E. Benz,et al. Lactoferrin gene promoter: structural integrity and nonexpression in HL60 cells. , 1992, Blood.
[17] T. Papayannopoulou,et al. Integrin expression profiles during erythroid differentiation. , 1992, Blood.
[18] T. Carlos,et al. A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA- dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components , 1992, The Journal of cell biology.
[19] A. Sonnenberg,et al. Molecular cloning of the human α6 integrin subunit , 1991 .
[20] V. Dixit,et al. Human neutrophil adherence to thrombospondin occurs through a CD11/CD18-independent mechanism. , 1991, Journal of immunology.
[21] E. Dmitrovsky,et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.
[22] R Berger,et al. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). , 1991, Blood.
[23] R Berger,et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.
[24] R. Luksch,et al. Expression of integrins in human bone marrow , 1990, British journal of haematology.
[25] Josephine C. Adams,et al. Changes in keratinocyte adhesion during terminal differentiation: Reduction in fibronectin binding precedes α 5 β 1 integrin loss from the cell surface , 1990, Cell.
[26] L. Liotta,et al. Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events , 1990, The Journal of cell biology.
[27] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[28] H. Lodish,et al. A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes , 1987, The Journal of cell biology.
[29] H. Koeffler,et al. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. , 1982, The Journal of clinical investigation.
[30] H. Koeffler,et al. INHIBITION OF THE CLONAL GROWTH OF HUMAN MYELOID LEUKEMIA CELLS , 1982 .
[31] S. Collins,et al. Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .
[32] S. Collins,et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Newburger,et al. Activity and activation of the granulocyte superoxide-generating system. , 1980, Blood.
[34] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[35] P. Newburger,et al. Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation , 1979, The Journal of cell biology.
[36] B. Babior,et al. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.